Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Multiple Myeloma, Daratumumab

Meletios Dimopoulos

MD

🏢University of Athens School of Medicine🌐Greece

Professor and Chair, Department of Clinical Therapeutics

88
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Meletios Dimopoulos at the University of Athens is a leading European myeloma expert who led the POLLUX (daratumumab-Rd) and CASTOR (daratumumab-Vd) trials that established daratumumab combinations as relapsed myeloma standards. He is also an expert in Waldenstrom macroglobulinemia and has contributed to Greek and European cooperative group myeloma research for over three decades.

Share:

🧪Research Fields 研究领域

multiple myeloma
daratumumab
Waldenstrom macroglobulinemia
POLLUX trial
CASTOR trial

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-02-01 | All information from publicly available academic sources

关注 Meletios Dimopoulos 的研究动态

Follow Meletios Dimopoulos's research updates

留下邮箱,当我们发布与 Meletios Dimopoulos(University of Athens School of Medicine)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment